Ultra-Low Endotoxin Fetal Bovine Serum (FBS)
It is produced by screening fetal bovine plasma with endotoxin levels below 0.1 EU/mL, followed by triple 0.1μm sterile filtration and rigorous aseptic processing to ensure a final endotoxin concentration of 0.1 EU/mL. It is specifically designed for endotoxin-sensitive experimental systems, including immune cells, stem cells, primary cells, skin absorption models, and biopharmaceutical R&D.
Enhanced Stability and Reproducibility
While preserving the full activity of growth factors, proteins, and essential nutrients, this product significantly enhances cell health and experimental reproducibility. The ultra-low endotoxin profile effectively prevents cellular stress responses, signaling pathway interference, and experimental data bias, making it the ideal choice for high-end scientific research and biopharmaceutical manufacturing.